International Association for the Study of Lung Cancer
Tracked across 2 events · 12 articles · First seen Jul 20, 2026 · Last active Sep 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Akeso announced that a pre-specified interim analysis of overall survival (OS) in the Phase III HARMONi-2 (AK112-303) trial, assessed by the Independent Data Monitoring Committee, met the key secondary OS endpoint. Ivonescimab, Akeso's first-in-class PD-1/VEGF…
Impact: The IASLC organized the 2026 World Conference on Lung Cancer where the HARMONi-2 OS data were published and presented as a late-breaking abstract.
Jul 20, 2026 · 6 articles
Tech
Cullinan Therapeutics announced that it will host a virtual event for analysts and institutional investors on September 14, 2026, at 8:00 a.m. ET to discuss results from the planned interim analysis of the Phase 3…
Impact: The International Association for the Study of Lung Cancer hosts the WCLC where the REZILIENT3 interim data were presented, providing the scientific venue for the disclosure.
Sep 10, 2026 · 6 articles
30
International Association for the Study of Lung Cancer published abstract dataIvonescimab HARMONi-2...
ERGEN INTELLIGENCE
Track International Association for the Study of Lung Cancer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard